HARNACK U[au] - Search Results

Year	Number of Results
2001	2
2004	2
2008	2
2009	1
2010	2
2011	4
2018	2
2025	0

1

Generation of an immortalized human CD4+ T cell clone inhibiting tumor growth in mice.

Pecher G, Harnack U, Günther M, Hummel M, Fichtner I, Schenk JA. Pecher G, et al. Among authors: harnack u. Biochem Biophys Res Commun. 2001 May 18;283(4):738-42. doi: 10.1006/bbrc.2001.4846. Biochem Biophys Res Commun. 2001. PMID: 11350045

2

Efficient gene transfer into murine embryonic stem cells by nucleofection.

Lorenz P, Harnack U, Morgenstern R. Lorenz P, et al. Among authors: harnack u. Biotechnol Lett. 2004 Oct;26(20):1589-92. doi: 10.1023/B:BILE.0000045658.33723.d6. Biotechnol Lett. 2004. PMID: 15604802

3

Role of soluble β-(1-3),(1-6)-D-glucan from Saccharomyces cerevisiae in the murine P388 ascites tumor model.

Harnack U, Eckert K, Pecher G. Harnack U, et al. In Vivo. 2011 Mar-Apr;25(2):185-9. In Vivo. 2011. PMID: 21471533

4

Down-regulation of the human tumor antigen mucin by gemcitabine on the pancreatic cancer cell line capan-2.

Dorn DC, Harnack U, Pecher G. Dorn DC, et al. Among authors: harnack u. Anticancer Res. 2004 Mar-Apr;24(2B):821-5. Anticancer Res. 2004. PMID: 15161033 Free article.

5

IL-1 receptor antagonist anakinra enhances tumour growth inhibition in mice receiving peptide vaccination and beta-(1-3),(1-6)-D-glucan.

Harnack U, Johnen H, Pecher G. Harnack U, et al. Anticancer Res. 2010 Oct;30(10):3959-65. Anticancer Res. 2010. PMID: 21036709

6

Comparison of the effect of orally administered soluble beta-(1-3),(1-6)-D-glucan and of G-CSF on the recovery of murine hematopoiesis.

Harnack U, Eckert K, Fichtner I, Pecher G. Harnack U, et al. In Vivo. 2010 Jan-Feb;24(1):59-63. In Vivo. 2010. PMID: 20133977

7

Glyco-Engineered Anti-Human Programmed Death-Ligand 1 Antibody Mediates Stronger CD8 T Cell Activation Than Its Normal Glycosylated and Non-Glycosylated Counterparts.

Goletz C, Lischke T, Harnack U, Schiele P, Danielczyk A, Rühmann J, Goletz S. Goletz C, et al. Among authors: harnack u. Front Immunol. 2018 Jul 16;9:1614. doi: 10.3389/fimmu.2018.01614. eCollection 2018. Front Immunol. 2018. PMID: 30061887 Free PMC article.

8

Antibody-based delivery of tumor necrosis factor (L19-TNFα) and interleukin-2 (L19-IL2) to tumor-associated blood vessels has potent immunological and anticancer activity in the syngeneic J558L BALB/c myeloma model.

Menssen HD, Harnack U, Erben U, Neri D, Hirsch B, Dürkop H. Menssen HD, et al. Among authors: harnack u. J Cancer Res Clin Oncol. 2018 Mar;144(3):499-507. doi: 10.1007/s00432-017-2564-6. Epub 2018 Jan 11. J Cancer Res Clin Oncol. 2018. PMID: 29327244 Free PMC article.

9

Impact of antigen-unloaded immature dendritic cells on antileukemic T-cell cytotoxicity.

Harnack U, Pecher G. Harnack U, et al. Anticancer Res. 2008 Sep-Oct;28(5A):2831-5. Anticancer Res. 2008. PMID: 19035318 Free article.

10

Oral administration of a soluble 1-3, 1-6 beta-glucan during prophylactic survivin peptide vaccination diminishes growth of a B cell lymphoma in mice.

Harnack U, Eckert K, Fichtner I, Pecher G. Harnack U, et al. Int Immunopharmacol. 2009 Oct;9(11):1298-303. doi: 10.1016/j.intimp.2009.07.013. Epub 2009 Aug 4. Int Immunopharmacol. 2009. PMID: 19664725

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

15 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15 results

Results by year